Inactive Instrument

VICS VANT Stock

VCKA

KYG9440B1077

Vickers Vantage Corp. I is a Singapore-based blank check company. The Company seeks to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company's subsidiary includes Vantage Merger Sub Inc. The Company is not engaged in any operations nor generates any revenues.

Employees

Sector

More about the company

10/11/22	Vickers Vantage Corp. I(NasdaqCM:VCKA) dropped from NASDAQ Composite Index	CI
10/11/22	Scilex Holding Company completed the acquisition of Vickers Vantage Corp. I from Vickers Venture Fund VI L.P. and Vickers Venture Fund VI Pte Ltd, managed by Vickers Venture Partners, Shaolin Capital Management LLC, Hudson Bay Capital Management LP and others in a reverse merger transaction.	CI
04/11/22	Vickers Vantage Corp. I Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
12/08/22	Vickers Vantage Corp. I Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
07/07/22	Sorrento Therapeutics Unit Scilex Plans to Acquire Ancora Medical	MT
16/05/22	Vickers Vantage Corp. I Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
11/04/22	Vickers Vantage I Extends Time to Complete Business Combination by Three Months	MT
25/03/22	Sorrento Therapeutics Unit Scilex Enters Deal with B Riley Financial for $5 Billion Financing Facility	MT
18/03/22	Sorrento's Scilex Says Semdexa Reduces Pain in Late-Stage Sciatica Trial; Scilex to Merge with Blank Check Firm	MT
25/02/22	Vickers Vantage Corp. I Reports Earnings Results for the Full Year Ended December 31, 2021	CI
24/02/22	Vickers Vantage Corp. I Auditor Raises 'Going Concern' Doubt	CI
07/01/22	Vickers Vantage Corp. I Extends Deadline to Complete SPAC Deal	MT
06/12/21	Sorrento Unit Scilex Plans Business Combination With Blank-Check Firm Vickers Vantage Corp I	MT

11/11/22	Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. and Vickers Vantage Corp. I Announce the Closing of their Previously Announced Business Combination	AQ
11/11/22	Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics Inc. Debuts on Nasdaq Under Ticker 'SCLX'	AQ
10/11/22	VICKERS VANTAGE CORP. I : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
04/11/22	VICKERS VANTAGE CORP. I Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
01/11/22	Scilex Holding Company a Sorrento Company and Vickers Vantage Corp. I Announce Effectiveness of Registration Statement on Form S-4, Date of Vickers Vantage Extraordinary General Meeting to Approve Proposed Business Combination	AQ

Date	Insider	Type	Main position	Quantity	% Market Cap.
11/10/22 A	Vickers Venture Fund Vi Pte Ltd.	Others	Company	5,840,000	42.3188%
1/6/21 A	Suneel Kaji	Other	Director	25,000	-
1/6/21 A	Steven Myint	Other	Director	25,000	-

VICS VANT Stock

Stocks

VCKA

KYG9440B1077

Latest news : VICS VANT

Press Releases: VICS VANT

Quotes and Performance

Latest insider transactions

Company Profile